Daily Oncology News

The ESMO OncologyPRO news, provided in partnership with medwireNews, ensures that you're always kept up to date with the latest developments in the field of medical oncology. You can browse articles by date or by topic.

Browse archives for older articles from 2017 , 2016 , 2015 (all articles may be found in search)

Did you know how medwireNews writes our articles?


Date Title Topic
22 Feb 2019 Sacituzumab Govitecan-hziy Promise For Refractory Metastatic TNBC Highlighted Breast Cancer - Clinical Research - Anticancer Agents
21 Feb 2019 Denosumab Use Boosts Disease-Free Survival For HR-Positive Early Breast Cancer Patients Breast Cancer - Anticancer Agents - Supportive Measures
20 Feb 2019 Neuroendocrine Tumour Treatments Reviewed Neuroendocrine Tumours - Anticancer Agents
18 Feb 2019 Pembrolizumab–Axitinib Combination Superior To Sunitinib For Advanced RCC Renal Cell Cancer - Anticancer Agents - Immunotherapy
15 Feb 2019 ARAMIS Demonstrates Darolutamide Benefit For Nonmetastatic CRPC Prostate Cancer - Anticancer Agents
14 Feb 2019 Stereotactic Ablative Body Radiotherapy Supported For Inoperable Stage I NSCLC Non-Small Cell Lung Cancer - Radiation Oncology
13 Feb 2019 Pembrolizumab–Trastuzumab May Offer PANACEA For Trastuzumab-Resistant Breast Cancer Breast Cancer - Clinical Research - Anticancer Agents - Immunotherapy
12 Feb 2019 Radium-Anti-Androgen Combination Not Recommended For mCRPC Prostate Cancer - Anticancer Agents - Radiation Oncology
11 Feb 2019 Meta-Analysis Shows Benefit Of Dose-Intense Chemotherapy For Early-Stage Breast Cancer Breast Cancer - Anticancer Agents
08 Feb 2019 Ultrasound-Guided Conservative Management May Be Feasible For Benign Ovarian Masses Ovarian Cancer - Imaging
07 Feb 2019 Celecoxib Use During Neoadjuvant Chemotherapy Linked To Poorer Breast Cancer Survival Breast Cancer - Anticancer Agents
06 Feb 2019 RAINFALL Washes Away First-Line Ramucirumab Plus Chemotherapy For Metastatic Gastric Cancer Gastric Cancer - Anticancer Agents
05 Feb 2019 Five-Year Findings Confirm Pembrolizumab Efficacy For Advanced Melanoma Melanoma - Immunotherapy
04 Feb 2019 Hypofractionated Radiotherapy Regimen Feasible After Mastectomy Breast Cancer - Radiation Oncology
01 Feb 2019 Docetaxel Use With ADT Challenged For High-Risk, Nonmetastatic Prostate Cancer Prostate Cancer - Anticancer Agents